Fingerprint
Dive into the research topics of 'A phase I trial of vorinostat and alvocidib in patients with relapsed, refractory, or poor prognosis acute leukemia, or refractory anemia with excess blasts-2'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically